UPSC conducted the NDA 2 on September 14 across various examination centres. According to the media reports, the outcome is expected in the last week of September 2025. The UPSC N ...
The UPSC NDA 2 2025 result, for the exam conducted on September 14, 2025, is anticipated in late September or October. Candidates can check their qualifying status on upsc.gov.in, with successful ...
Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...
What if you could get checked for colon cancer with only a routine blood draw? A new blood test in Michigan is making the process much easier. No bowel prep, no sedation and no awkward stool kit to ...
DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...
Dublin, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The "EU5 Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others" report has been added to ...
Sensitivity ranged from 0.095 to 0.998; specificity from 0.657 to 1.0; AUC from 0.52 to 1.0 across tests. (HealthDay News) — No controlled studies report benefits of screening with multicancer ...
Early cancer detection significantly improves treatment outcomes and survival rates. Recognizing warning signs like persistent coughs, bowel changes, unexplained bleeding, weight loss, or lumps is ...
A cohort study evaluating a tuberculosis (TB) prevention program among patients who received biologic therapy found a low risk for incident infection. Pretreatment screening with QuantiFERON-TB (QFT) ...
The FDA approved the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk for the disease, Guardant Health announced. According to the company, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback